Sector: Health Care
Director information for MEDPACE HOLDINGS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| August J. Troendle | Chief Executive Officer and Chairman of the Board | 69 | ["Chief Executive Officer and Chairman of the Board of Directors of Medpace", "Experience as a manager at Sandoz (Novartis)", "Medical Review Officer at the FDA", "Director for Coherus BioSciences, Inc.", "Director for Xenon Pharmaceuticals Inc.", "Director for LIB Therapeutics, Inc.", "Director for CinCor Pharma, Inc.", "Director for CinRx Pharma, LLC", "Medical Degree from the University of Maryland, School of Medicine", "Master of Business Administration from Boston University"] | [] | 2026 |
| Brian T. Carley | Director | 72 | ["Retired from Clubessential Holdings, LLC", "Served as Senior Vice President and Chief Financial Officer", "Extensive experience in financial and accounting fields", "Former audit partner at Deloitte & Touche LLP", "Former office managing partner at Arthur Andersen LLP", "Director of Assurex Health, Inc.", "Experience serving on boards of various organizations", "Bachelor of Science in Accountancy from the University of Illinois", "Retired Certified Public Accountant"] | [] | 2026 |
| Cornelius P. McCarthy III | Director | 66 | ["Managing Director and CEO of Fairmount Partners", "focused primarily on healthcare and pharmaceutical outsourced services", "former Vice President, Managing Director and Head of US Investment Banking at PMG/Investec", "Director of NMS Laboratories, Inc.", "former Director of Atlantic Research Services, LLC", "significant investment and financial experience", "experience in the CRO industry"] | [] | 2026 |
| Dani S. Zander | Director | 64 | ["Collaborative Professor in the Department of Pathology and Cell Biology at the University of South Florida Morsani College of Medicine", "MacKenzie Chair of the Department of Pathology and Laboratory Medicine at the University of Cincinnati", "Chief of Pathology and Laboratory Medicine for UC Health", "Chair of the Department of Pathology at Penn State", "Lung pathologist and cytopathologist with a focus on lung cancer and lung transplantation", "Editor of five pulmonary pathology and molecular pathology books", "Past president of the Association of Pathology Chairs", "Mentor for faculty, residents, and medical students"] | [] | 2026 |
| Femida H. Gwadry-Sridhar | Chief Executive Officer | 64 | ["Founder and Chief Executive Officer of Pulse Infoframe Inc.", "Academic appointments at Western University and University of Southern California", "Thought leader in real-world evidence", "Over 220 publications in top tier journals", "Lifetime fellow of the Canadian Institute of Health Research (CIHR)", "Experience as an executive in the biosciences industry"] | [] | 2026 |
| Fred B. Davenport, Jr. | Director | 74 | ["partner at the law firm of Murchison, Taylor & Gibson, PLLC", "focused on mergers and acquisitions, general corporate representation and estate planning", "former President of Pharmaceutical Product Development, Inc.", "former Executive Vice President and General Counsel of PPD", "tenured professor at Cameron School of Business", "experience in the CRO industry", "served on numerous community and non-profit boards"] | [] | 2026 |
| Jesse J. Geiger | President | 51 | ["Certified Public Accountant (inactive)", "Bachelor of Business Administration in Accounting from the University of Cincinnati"] | [] | 2026 |
